531752 — Biogen Pharmachem Industries Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsSpeculativeMicro CapNeutral

Annual balance sheet for Biogen Pharmachem Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.832	1.29	0.169	20.2	3.22
Net Total Accounts Receivable
Net Total Receivables	0.113	0.25	0.75	0.857	1.65
Total Inventory
Total Other Current Assets
Total Current Assets	19.3	1.54	0.919	26.7	4.87
Net Property, Plant And Equipment	0	0	—	—	—
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	549	548	568	920	994
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	8.15	2.38	3.02	0.9	3.12
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	8.15	2.38	3.02	0.9	3.12
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	541	546	565	919	991
Total Liabilities & Shareholders' Equity	549	548	568	920	994
Total Common Shares Outstanding